Unicocell Biomed Co., Ltd. (referred to as “Unicocell”, stock code: 6794), a company dedicated to the development of stem cell and regenerative medicine products, has recently been granted a Taiwan invention patent by the Taiwan Intellectual Property Office (Patent No. I920006), entitled “A method for culturing human dermal fibroblasts.” This patent further strengthens the Company’s technological capabilities in cell-derived product functional evaluation platforms and skin-related applications.
The patented technology is designed to optimize skin cell culture conditions and testing processes, enhancing the stability and consistency of analytical outcomes. It serves as a foundational platform to support the development of skin-related applications and provides a reliable technical basis for future research and development in skin care and aesthetic products.
Unicocell continues to expand the application of its cell-based technologies into the skin care and aesthetic markets, while actively advancing its international commercialization strategy. The Company’s exosome-related products have obtained cosmetic ingredient registration in Japan and have recently received approval from the Philippine Food and Drug Administration (Notification of Cosmetic Product), allowing for legal commercialization in the local market. These products also comply with regional regulatory requirements, including the ASEAN Cosmetic Directive, laying the groundwork for further expansion into Southeast Asian markets.
This patent approval aligns with Unicocell’s established international market development strategy. Moving forward, the Company will continue to evaluate the potential applications of this technology in skin conditioning and aesthetic applications, while adhering to regulatory requirements and industry trends across different markets. Unicocell remains committed to strengthening its technological platforms and global market presence, further enhancing its competitiveness in both domestic and international skin care and aesthetic sectors.
Contact: Ray Liu
Phone: 886-2-27922699
Mail: info@unicocell.com